Novavax Inc (NVAX)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account
Sell

$6.04

Buy

$6.05

arrow-down$-0.03 (-0.49%)

Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.
Prices updated at 07 May 2025, 17:05 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Profit margins

Created with Highcharts 7.2.2Gross margin (%)Operating margin (%)EBITDA margin (%)Net margin (%)20202021202220232024-2000-1500-1000-5000500

Valuation

Created with Highcharts 7.2.2Price earningsPrice / SalesPrice / Cash flow202120222023202420250510152025

Profit margins data table

YearGross margin (%)Operating margin (%)Net margin (%)EBITDA margin (%)EBITDA
202470.28-36.49-27.49-15.84-108m
202338.21-101.82-97.97-87.60-487m
202243.55-40.32-41.15-37.82-605m
2021100.00-853.61-882.55-850.66-1,681m
2020100.00-1,861.35-1,868.23-1,778.76-398m
2019--694.44-711.04-615.31-115m
2018--507.23-538.81-479.47-164m
2017--550.78-589.46-512.83-160m
2016--1,752.84-1,823.53-1,683.68-258m

Valuation data table

YearPrice / SalesPrice earningsPrice / Cash flow
20251.35--
20241.36--
20230.73--
20220.43--
20218.55-19.17
202026.22-86.18
20195.45--
201816.84--
201713.34--
201621.56--
201557.51--
Price/Forward earnings (YTD)
-5.67

Returns

Created with Highcharts 7.2.2Return on assets (%)Return on equity (%)Return on invested capital (%)20202021202220232024-1500-1000-5000

Debt profile

Created with Highcharts 7.2.2Financial leverage202020212022202320240123

Returns data table

YearReturn on assets (%)Return on equity (%)Return on invested capital (%)
2024-11.17--
2023-26.88--
2022-27.21--
2021-83.85-1,265.72-288.65
2020-47.65-189.60-65.49
2019-69.67--
2018-72.38--
2017-52.75--
2016-71.75-195.01-58.06

Debt profile data table

YearFinancial leverage
2024-
2023-
2022-
2021-
20202.52
2019-
2018-
2017-
2016-
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.